TABLE 3.

Glycopeptide susceptibility

Gene	Species	MIC (μg/ml)		No. of isolates
		Vancomycin	Teicoplanin
vanA	E. faecium (n = 82)	256	>32	53
		256	32	19
		256	24	7
		256	16	2
		256	12	1
	E. faecalis (n = 2)	256	256	1
		256	4	1
vanB	E. faecium (n = 41)	256	256	1
		256	0.25–1.5	33
		128	1	1
		64	0.75–1	3
		24	0.5–0.75	2
		12	0.5	1
	E. faecalis (n = 10)	256	0.25	1
		128	0.38	1
		48	0.5–0.75	2
		32	0.5	2
		24	0.38	1
		16	0.5	1
		12	0.25	1
		8	0.25	1
vanC1	E. gallinarum (n = 42)	12	1	1
		8	0.5–1.5	20
		6	0.38–1	18
		4	0.75–1	2
		3	0.5	1
vanC2 or vanC3	E. casseliflavus (n = 9)	6	0.5–1	4
		4	0.5–1	5
None	E. faecium (n = 10)	1.5	0.75–1	3
		1	0.75–1	5
		0.75	0.125–1	2
	E. faecalis (n = 48)	16	0.38	2
		12	0.5	2
		4	0.38–0.75	4
		3	0.25–1	13
		2	0.25–0.75	19
		1.5	0.125–0.5	8
	E. durans (n = 2)	6	0.38	1
		4	0.125	1
	E. hirae (n = 2)	1	0.094	1
		0.75	0.094	1